Atypical femoral fractures associated with long-term bisphosphonate use
Open Access
- 6 May 2013
- journal article
- case report
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 185 (14) , 1248
Abstract
A 75-year-old woman with osteoporosis presented with a 2-year history of anterior thigh pain that was worse when standing and walking. She had taken alendronate for more than 20 years, which was replaced with annual zoledronic acid infusions for the last 3 years. On examination, she had an antalgicKeywords
This publication has 4 references indexed in Scilit:
- Atypical Femoral Fracture Risk in Patients Treated With BisphosphonatesArchives of internal medicine (1960), 2012
- Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate UseArchives of internal medicine (1960), 2012
- Effects of Continuing or Stopping Alendronate After 5 Years of Treatment. The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized TrialObstetrical & Gynecological Survey, 2007
- Effects of Continuing or Stopping Alendronate After 5 Years of TreatmentJAMA, 2006